Literature DB >> 21612986

An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions.

Tomislav Smoljanovic1, Ivan Bojanic.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21612986     DOI： 10.1016/j.spinee.2011.04.019

Source DB:  PubMed          Journal:  Spine J        ISSN： 1529-9430            Impact factor:   4.166


× No keyword cloud information.
  3 in total

1.  Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

Authors:  Brook I Martin; Jon D Lurie; Anna N A Tosteson; Richard A Deyo; Farrokh R Farrokhi; Sohail K Mirza
Journal:  Spine J       Date:  2014-12-15       Impact factor: 4.166

2.  Public awareness of the bone morphogenic protein controversy: Evidence from news publications.

Authors:  Doniel Drazin; Faris Shweikeh; Erich Wieshofer; Terrence T Kim; J Patrick Johnson
Journal:  Surg Neurol Int       Date:  2014-12-30

3.  Soft Tissue Swelling Associated with the Use of Recombinant Human Bone Morphogenetic Protein-2 in Long Bone Non-unions.

Authors:  Andrew Young; Adam Mirarchi
Journal:  J Orthop Case Rep       Date:  2015 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.